Intended for healthcare professionals

Feature Post-marketing Surveillance

Why the FDA can’t protect the public

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4753 (Published 03 November 2010) Cite this as: BMJ 2010;341:c4753